Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 19

Trial Status

Completed9

Role Distribution

Principal Investigator9
PI Rate100%

Activity Timeline

Clinical Trials (9)

NCT01893554Phase 1Completed
Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Respiratory Syncytial Virus Infections
PrincipalinvestigatorStart date: 2013-06-01
NCT00308412Phase 1Completed
Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants
Paramyxoviridae InfectionsVirus Diseases
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Janet Englund, MD

Seattle Children's Hospital

Related
1 trials

Shared therapeutic areas:

Metapneumovirus

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score14%

Matthew J Memoli, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
15 trials

Shared therapeutic areas:

Influenza, HumanVirus Diseases

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score10%

Veryl Hodges, DO

Clopton Clinic

Related
1 trials

Shared therapeutic areas:

Influenza, Human
Similarity Score5%

Shaukat A. Shah, MD

St. Joseph's Medical Associates, Stockton, CA 95204

Related
1 trials

Shared therapeutic areas:

Influenza, Human
Similarity Score5%

Keith S. Reisinger, MD, MPH

Primary Physicians Research, Inc

Related
1 trials

Shared therapeutic areas:

Influenza, Human
Similarity Score5%

Giuseppe D'Ignazio, MD

Source Unique Clinic

Related
1 trials

Shared therapeutic areas:

Influenza, Human
Similarity Score5%

Lawrence P. Schwartz, MD

HCCA Clinical Research Solutions, New York, NY 10016

Related
1 trials

Shared therapeutic areas:

Influenza, Human
Similarity Score5%

Terry L Poling, MD

Heartland Research Associates, LLC, Wichita, KS 67207

Related
1 trials

Shared therapeutic areas:

Influenza, Human
Similarity Score5%

Michael Warren, MD

Research Across America at Oyster Point Family Health Center

Related
1 trials

Shared therapeutic areas:

Influenza, Human
Similarity Score5%

Douglas W Mapel, MD

Clinical Trial Connection, Flagstaff, AZ 86001

Related
1 trials

Shared therapeutic areas:

Influenza, Human
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT01893554Phase 1PrincipalInvestigator

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children

Respiratory Syncytial Virus Infections
Completed
NCT00308412Phase 1PrincipalInvestigator

Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants

Paramyxoviridae InfectionsVirus Diseases
Completed
NCT00366782Phase 1PrincipalInvestigator

Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults

Paramyxoviridae InfectionsVirus Diseases
Completed
NCT00380237Phase 1PrincipalInvestigator

Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)

InfluenzaVirus Diseases
Completed
NCT00488046Phase 1PrincipalInvestigator

Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

InfluenzaVirus Diseases
Completed
NCT00641017Phase 1PrincipalInvestigator

Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine

ParainfluenzaVirus Diseases
Completed
NCT01255410Phase 1PrincipalInvestigator

Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine

Metapneumovirus
Completed
NCT01459198Phase 1PrincipalInvestigator

Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections
Completed
NCT01852266Phase 1PrincipalInvestigator

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections
Completed

All 9 trials loaded